Amphastar Pharmaceuticals, Inc. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Amphastar Pharmaceuticals, Inc. (AMPH) holds an ST Score of 51.3 out of 100 (C+), with its strongest factor being Profitability (A) and its weakest Forecast (D+). Analysts rate AMPH Hold across 12 ratings with a $21.25 average price target (-0.1% vs the current $24.48).
- Strongest
- ProfitabilityA
- Weakest
- ForecastD+
All factor grades
- ProfitabilityA
- MomentumA-
- ValuationC
- GrowthC
- Financial StrengthD+
- ForecastD+
- Piotroski6/9
Contact
AMPH stock: frequently asked questions
What is AMPH's ST Score?
Amphastar Pharmaceuticals, Inc. (AMPH) has an ST Score of 51.3 out of 100, an overall grade of C+. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is AMPH a buy, sell, or hold?
Wall Street's consensus rating on AMPH is Hold based on 12 analyst ratings. Our own ST Score grades it C+ (51.3/100). This is data, not investment advice — always do your own research.
What is AMPH's valuation grade?
Amphastar Pharmaceuticals, Inc. (AMPH) earns a valuation grade of C, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is AMPH's growth grade?
Amphastar Pharmaceuticals, Inc. (AMPH) earns a growth grade of C, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is AMPH's profitability grade?
Amphastar Pharmaceuticals, Inc. (AMPH) earns a profitability grade of A, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is AMPH's financial strength grade?
Amphastar Pharmaceuticals, Inc. (AMPH) earns a financial strength grade of D+, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for AMPH?
The average analyst price target for Amphastar Pharmaceuticals, Inc. (AMPH) is $21.25 from 12 analysts, which is -0.1% versus the recent price of $24.48.
What is AMPH's Piotroski score?
Amphastar Pharmaceuticals, Inc. (AMPH) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.